Insider · CIK 0001807412

D'Alvise Janelle

Reports to the SEC for 1 company · LAVAL, A8

Transactions

Companies

Filings

CIK

0001807412

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-22	GRCEGrace Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, PRESIDENT & CEO	AAward	+560K sh	—	—	560,000
2021-11-12	GRCEGrace Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, PRESIDENT & CEO	AAward	+656K sh	—	—	655,500

C/O ACASTI PHARMA INC. 545 PROMENADE DU CENTROPOLIS, SUITE 100

LAVAL, A8, H7T 0A3